|
PCP
|
NPP & MA
|
Control
|
p values2
|
---|
N screened positive
|
N received BI/RT
|
%
|
N screened positive
|
N received BI/RT
|
%
|
N screened positive
|
N received BI/RT
|
%
|
---|
Medical center
|
1
|
90
|
51
|
56.67
|
1916
|
47
|
2.45
|
185
|
1
|
0.54
|
b, c
|
2
|
129
|
16
|
12.40
|
1849
|
24
|
1.30
|
41
|
1
|
2.44
|
b’’’, c
|
3
|
51
|
8
|
15.69
|
123
|
5
|
4.07
|
216
|
3
|
1.39
|
b’, c’’
|
4
|
241
|
141
|
58.51
|
1829
|
96
|
5.25
|
6
|
0
|
0.00
|
b’’, c
|
5
|
145
|
17
|
11.72
|
229
|
23
|
10.04
|
142
|
3
|
2.11
|
a’, b’’
|
6
|
246
|
120
|
48.78
|
2114
|
69
|
3.26
|
19
|
1
|
5.26
|
b’, c
|
7
|
394
|
200
|
50.76
|
172
|
9
|
5.23
|
26
|
0
|
0.00
|
b, c
|
8
|
503
|
153
|
30.42
|
1776
|
47
|
2.65
|
137
|
9
|
6.57
|
a’’, b, c
|
9
|
306
|
15
|
4.90
|
54
|
16
|
29.63
|
9
|
0
|
0.00
|
a’’’, c
|
10
|
697
|
545
|
78.19
|
4260
|
140
|
3.29
|
175
|
7
|
4.00
|
b, c
|
11
|
306
|
115
|
37.58
|
1259
|
55
|
4.37
|
176
|
5
|
2.84
|
b, c
|
All
|
3108
|
1381
|
44.43
|
15581
|
531
|
3.41
|
1132
|
30
|
2.65
|
b, c
|
-
1Chi-square tests were used to compare the proportions of patients screened between each of the two intervention arms vs. control as well as between the two intervention arms
-
2a: p<0.0001, NPP & MA vs. Control. a’ p<0.01, NPP & MA vs. Control. a’’: p<0.05, NPP & MA vs. Control. a’’’: p<0.10, NPP & MA vs. Control. b: p<0.0001, PCP vs. Control. b’: p<0.001, PCP vs. Control. b’’: p<0.01, PCP vs. Control. b’’’: p<0.10, PCP vs. Control. c: p<0.0001, NPP & MA vs. PCP. c’: p<0.01, NPP & MA vs. PCP. c’’: p<0.05, NPP & MA vs. PCP